Serrated polyps: Critical precursors to colorectal cancer

Expert Review of Gastroenterology and Hepatology

Volumn 5, Issue 5, 2011, Pages 627-635

  Sweetser, Seth ^a   Smyrk, Thomas C ^b   Sugumar, Aravind ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

colorectal cancer; CpG island methylator phenotype; hyperplastic polyps; microsatellite instability; mismatch repair; serrated polyposis syndrome; serrated polyps; sessile serrated adenoma; traditional serrated adenoma

Indexed keywords

CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; COLON POLYP; COLON POLYPOSIS; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CPG ISLAND; DNA METHYLATION; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOLECULAR PATHOLOGY; ONCOGENE K RAS; PHENOTYPIC VARIATION; POLYPECTOMY; RECTUM POLYP; REVIEW; RISK FACTOR;

ADENOMA; CELL TRANSFORMATION, NEOPLASTIC; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 80052808599     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.11.67     Document Type: Review

References (82)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin. 58, 71-96 (2008).
2. Carragher LAS, Snell KR, Giblett SM et al. V600E BRAF induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16. EMBO Mol. Med. 11, 458-471 (2010).
3. Snover DC, Ahnen DJ, Burt RW et al. Serrated polyps of the colon and rectum and serrated ('hyperplastic) polyposis. In: WHO Classification of Tumours. Pathology and Genetics. Tumours of the Digestive System (4th Edition). Bozman FT, Carneiro F, Hruban RH (Eds). Springer-Verlag, Berlin, Germany (2010).
4. Mäkinen MJ. Colorectal serrated adenocarcinoma. Histopathology 50, 131-150 (2007). (Pubitemid 44953404)
5. Spring KJ, Zhao ZZ, Karamatic R et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131, 1400-1407 (2006). (Pubitemid 44708940)
6. OBrien MJ. Hyperplastic and serrated polyps of the colorectum. Gastroenterol. Clin. N. Am. 36, 947-968, viii (2007).
7. Boparai KS, Dekker E, van Eden S et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expresion of MYH-associated polyposis. Gastroenterology 135, 2014-2018 (2008).
8. Goldstein NS, Bhanot P, Odish E, Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am. J. Clin. Pathol. 119, 778-796 (2003). (Pubitemid 37047838)
9. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am. J. Surg. Pathol. 27, 65-81 (2003). (Pubitemid 36014900)
10. Goldstein NS. Clinical significance of (sessile) serrated adenomas: another piece of the puzzle. Am. J. Clin. Pathol. 123, 329-330 (2005). (Pubitemid 40315073)
11. Goldstein NS. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am. J. Clin. Pathol. 125, 132-145 (2006). (Pubitemid 43089736)
12. Groff RJ, Nash R, Ahnen DJ. Significance of serrated polyps of the colon. Current Gastroenterol. Rep. 10, 490-498 (2008).
13. Carr NJ, Mahajan H, Tan KL, Hawkins NJ, Ward RL. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J. Clin. Pathol. 62, 516-518 (2009).
14. Arain MA, Sawhney M, Sheikh S et al. CIMP status of interval colon cancers: another piece to the puzzle. Am. J. Gastroenterol. 105, 1189-1195 (2010).
15. Goldstein NS. Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. Am. J. Clin. Pathol. 125, 146-153 (2006). (Pubitemid 43089737)
16. Kambara T, Simms LA, Whitehall VL et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53, 1137-1144 (2004). (Pubitemid 38961968)
17. Kim YH, Kakar S, Cun L, Deng G, Kim YS. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. J. Int. Cancer 123, 2587-2593 (2008).
18. Rex DK, Rahmani EY. New endoscopic finding associated with hyperplastic polyps. Gastrointest. Endosc. 50, 704-706 (1999). (Pubitemid 29518060)
19. Tolliver KA, Rex DK. Colonoscopic polypectomy. Gastroenterol. Clin. North Am. 37, 229-251 (2008). (Pubitemid 351289027)
20. Cunningham KS, Riddell RH. Serrated mucosal lesions of the colorectum. Curr. Opin. Gastroenterol. 22, 48-53 (2006). (Pubitemid 44124282)
21. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138, 2088-2100 (2010).
22. Li SC, Burgart L. Histopathology of serrated adenoma, its variants, and differentiation from conventional adenomatous and hyperplastic polyps. Arch. Pathol. Lab. Med. 131, 440-445 (2007). (Pubitemid 46365526)
23. Snover DC, Jass JR, Fenoglio-Preiser C et al. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am. J. Clin. Pathol. 124, 380-391 (2005). (Pubitemid 41232924)
24. Snover DC. Serrated polyps of the large intestine. Semin. Diagn. Pathol. 22, 301-308 (2005). (Pubitemid 44137410)
25. Oka S, Tanaka S, Hiyama T et al. Clinicopathologic and endoscopic features of colorectal serrated adenoma: differences between polypoid and superficial types. Gastrointest. Endosc. 59, 213-219 (2004). (Pubitemid 38199214)
26. Torlakovic EE, Gomez JD, Driman DK et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am. J. Surg. Pathol. 32, 21-29 (2008).
27. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am. J. Surg. Pathol. 14, 524-537 (1990). (Pubitemid 20172523)
28. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525-532 (1988).
29. Weisenberger DJ, Siegmund KD, Campan M et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38, 787-793 (2006). (Pubitemid 43980599)
30. Ogino S, Cantor M, Kawasaki T et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55, 1000-1006 (2006). (Pubitemid 43962613)
31. Jass JR. Molecular heterogeneity of colorectal cancer: implications for cancer control. Surg. Oncol. 16, S7-S9 (2007).
32. Minoo P, Moyer MP, Jass JR. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. J. Pathol. 212, 124-133 (2007). (Pubitemid 46852090)
33. Young J, Jass JR. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol. 15, 1778-1784 (2006). (Pubitemid 44664248)
34. Jass JR. Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat. Clin. Prac. Oncol. 2, 398-405 (2005). (Pubitemid 43115008)
35. Sugumar A, Sinicrope FA. Serrated polyps of the colon. F1000 Medicine Reports 2, 89 (2010).
36. Beach R, Chan AO, Wu TT et al. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am. J. Pathol. 166, 1069-1075 (2005). (Pubitemid 40524431)
37. Rajagopalan H, Bardelli A, Lengauer C et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418, 934 (2002). (Pubitemid 34976022)
38. Ogino S, Kawasaki T, Kirkner GJ et al. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J. Mol. Diagn. 8, 582-588 (2006). (Pubitemid 44774157)
39. Whitehall VL, Walsh MD, Young J et al. Methylation of 0-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res. 61, 827-830 (2001). (Pubitemid 32174386)
40. Ogino S, Kawasaki T, Kirkner GJ et al. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Gut 56, 1564-1571 (2007). (Pubitemid 350033195)
41. Yamagata S, Muto T, Uchida Y et al. Polypoid growth and K-ras codon 12 mutation in colorectal cancer. Cancer 75, 953-957 (1995).
42. Samowitz WS, Albertsen H, Herrick J et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129, 837-845 (2005). (Pubitemid 41242676)
43. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum. Pathol. 42, 1-10 (2011).
44. Jeevaratnam P, Cottier DS, Browett PJ, Van De Water NS, Pokos V, Jass JR. Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. J. Pathol. 179, 20-25 (1996). (Pubitemid 26180082)
45. Burt R, Jass JR. Hyperplastic polyposis. In: Pathology and Genetics of Tumours of the Digestive System. Hamilton SR, Aaltonen LA (Eds). IARC Press, Lyon, France, 135-136 (2000).
46. Burt RW, Samowitz WS. Serrated adenomatous polyposis: a new syndrome? Gastroenterology 110, 950-952 (1996). (Pubitemid 26071865)
47. Jass JR. Gastrointestinal polyposes: clinical, pathological and molecular features. Gastroenterol. Clin. North Am. 36, 927-946 (2007). (Pubitemid 350051706)
48. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50, 113-130 (2007). (Pubitemid 44953403)
49. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am. J. Pathol. 160, 529-536 (2002). (Pubitemid 34160330)
50. Williams GT, Arthur JF, Bussey HJ et al. Metaplastic polyps and polyposis of the colorectum. Histopathology 4, 155-170 (1980). (Pubitemid 10117088)
51. Ferrandez A, Samowitz W, DiSario JA et al. Phenotypic characteristics and risk factor development in hyperplastic polyposis: case series and literature review. Am. J. Gastroenterol. 99, 2012-2018 (2004). (Pubitemid 39421248)
52. Young J, Jenkins M, Parry S et al. Serrated pathway colorectal cancer in the population: genetic consideration. Gut 56, 1453-1459 (2007). (Pubitemid 47517843)
53. Chow E, Lipton L, Lynch E et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 131, 30-39 (2006). (Pubitemid 44015745)
54. Lage P, Cravo M, Sousa R et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am. J. Gastroenterol. 99, 1779-1784 (2004). (Pubitemid 39237508)
55. Rashid A, Houlihan PS, Booker S et al. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 119, 323-332 (2000). (Pubitemid 30621982)
56. Chan AO, Issa JP, Morris JS et al. Concordant CpG island methylation in hyperplastic polyposis. Am. J. Pathol. 160, 529-536 (2002). (Pubitemid 34160330)
57. Minoo P, Baker K, Goswami R et al. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55, 1467-1474 (2006). (Pubitemid 44476793)
58. Wallace K, Grau MV, Ahnen D et al. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol. 18, 2310-2317 (2009).
59. Limsui D, Vierkant RA, Tillmans LS et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J. Natl Cancer Inst. 102, 1012-1022 (2010).
60. Goldstein NS. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am. J. Clin. Pathol. 125, 132-145 (2006). (Pubitemid 43089736)
61. Sheridan TB, Fenton H, Lewin MR et al. Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions 'caught in the act. Am. J. Clin. Pathol. 126, 564-571 (2006). (Pubitemid 44498506)
62. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J. Clin. Pathol. 63, 665-668 (2010).
63. Hiroaka S, Kato J, Fujiki S et al. The presence of large serrated polyps increases the risk of colorectal cancer. Gastroenterology 139, 1503-1510 (2010).
64. Schriener MA, Weiss DG, Lieberman DA et al. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology 139, 1497-1502 (2010).
65. Terdiman JP, McQuaid KR. Surveillance guidelines should be updated to recognize the importance of serrated polyps. Gastoenterology. 139, 1444-1447 (2010).
66. East JE, Saunders BP, Jass JR. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol. Clin North Am. 37, 25-46, v (2008).
67. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann. Intern. Med. 150, 1-8 (2009).
68. Farrar WD, Sawhney MS, Nelson DB, Lederle FA, Bond JH. Colorectal cancers found after a complete colonoscopy. Clin. Gastroenterol. Hepatol. 4(10), 1259-1264 (2006). (Pubitemid 44512220)
69. Hetzel J, Huang CS, Coukos JA et al. Variation in the detection of serrated polyps in an average risk colorrectal cancer screening cohort. Am. J. Gastroenterol. 105(12), 2656-2664 (2010).
70. Rex DK, Hewett DG, Snover DC. Detection targets for colonoscopy: from variable detection to validation. Am. J. Gastroenterol. 105, 2665-2669 (2010).
71. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N. Engl. J. Med. 355, 2533-2541 (2006). (Pubitemid 44917501)
72. East JE, Suzuki N, Arebi N, Bassett P, Saunders BP. Position changes improve visibility during colonoscope withdrawal: a randomized, blinded, crossover trial. Gastrointest. Endosc. 65, 263-269 (2007). (Pubitemid 46148890)
73. Froehlich F, Wietlisbach V, Gonvers JJ, Burnand B, Vader JP. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest. Endosc. 61, 378-384 (2005). (Pubitemid 40349029)
74. Trecca A, Gai F, Di Lorenzo GP et al. [Conventional colonoscopy versus chromoendoscopy and magnifying endoscopy for the diagnosis of colorectal lesions: a comparative prospective study in 995 patients]. Chirurgia Italiana 56, 31-36 (2004).
75. Hussain FTN, Yab TC, Harrington JJ et al. Noninvasive detection of serrated colorectal polyps by stool assay of methylated vimentin and mutant BRAF genes. Gastroenterology 138(5), S-102 (2010).
76. Huang CS, Farraye FA, Yang S et al. The clinical significance of serrated polyps. Am. J. Gastroenterol. 106, 229-240 (2011).
77. Li D, Jin C, McCulloch C et al. Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am. J. Gastroenterol. 104, 695-702 (2009).
78. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology 110, 748-755 (1996). (Pubitemid 26071842)
79. Pabby A, Schoen RE, Weissfeld JL et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest. Endosc. 61, 385-391 (2005). (Pubitemid 40349030)
80. Chandra A, Sheikh AA, Cerar A, Talbot IC. Clinico-pathological aspects of colorectal serrated adenomas. World J. Gastroenterol. 12, 2770-2772 (2006). (Pubitemid 43796490)
81. Laiho P, Kokko A, Vanharanta S et al. Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis. Oncogene 26, 312-320 (2007). (Pubitemid 46095743)
82. Garcia-Solano J, Perez-Guillermo M, Conesa-Zamora P et al. Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum. Pathol. 41, 1359-1368 (2010).